Efficient and Isoform-Selective Inhibition of Cellular Gene Expression by Peptide Nucleic Acids

Biochemistry

Volumn 43, Issue 7, 2004, Pages 1921-1927

  Liu, Yinghui ^a   Braasch, Dwaine A ^a   Nulf, Christopher J ^a   Corey, David R ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENES; OLIGOMERS; PROTEINS; RNA;

CELL PROLIFERATION; GENE EXPRESSION;

BIOCHEMISTRY;

CAVEOLIN 1; ISOPROTEIN; OLIGOMER; PEPTIDE NUCLEIC ACID; PHOSPHATE; PHOSPHOROTHIOIC ACID;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG RESEARCH; FEMALE; GENE; GENE EXPRESSION REGULATION; GENOMICS; HUMAN; HUMAN CELL; MAMMAL; NUCLEIC ACID PROBE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN VARIANT; RNA TRANSLATION; START CODON;

CAVEOLIN 1; CAVEOLINS; DOWN-REGULATION; GENE SILENCING; GENE TARGETING; GROWTH INHIBITORS; HELA CELLS; HUMANS; OLIGONUCLEOTIDES, ANTISENSE; PEPTIDE CHAIN INITIATION, TRANSLATIONAL; PEPTIDE NUCLEIC ACIDS; PROTEIN BIOSYNTHESIS; PROTEIN ISOFORMS; PROTEIN SYNTHESIS INHIBITORS; PROTEINS; RNA, MESSENGER; RNA, SMALL INTERFERING; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSFECTION;

EUKARYOTA; MAMMALIA;

EID: 1242352936     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi0358519     Document Type: Article

References (39)

1. Stein, C. A. (1999) Keeping the biotechnology of antisense in context. Nat. Biotech. 17, 209.
2. Elbashir, S. M., Harboth, J., Lendeckel, W., Yalcin, A., Weber, K., and Tuschl, T. (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494-498.
3. Opalinska, J. B., and Gerwirtz, A. M. (2002) Nucleic acid therapeutics: basic principles and recent applications. Nat. Rev. Drug Discovery 1, 503-514.
4. Nielsen, P. G., Egholm, M., Berg, R. H., and Buchardt, O. (1991) Sequence-selective recognition of DNA by strand displacement with a thymine substituted polyamide. Science 254, 1497-1500.
5. Egholm, M., Buchardt, O., Christensen, L. R., Behrens, C., Freier, S. M., Driver, D. A., Berg, R. H., Kim, S. K., Norden, B., and Nielsen, P. E. (1993) PNA hybridizes to complementary oligonucleotides obeying Watson-Crick hydrogen bonding rules. Nature 365, 566-568.
6. Demidov, V. V., Potaman V. N., Frank-Kamenetskii, M. D., Egholm, M., Buchardt, O., Sonnichsen, S. H., and Nielsen, P. E. (1994) Stability of peptide nucleic acids in human serum and cellular extracts. Biochem. Pharmacol. 48, 1310-1313.
7. Hamilton, S. E., Iyer, M., Norton, J. C., and Corey, D. R. (1996) Specific and nonspecific inhibition of transcription by DNA, PNA, and phosphorothioate promoter analog complexes. Bioorg. Med. Chem. Lett. 6, 2897-2900.
8. Knudsen, H., and Nielsen P. E. (1996) Antisense properties of duplex- and triplex-forming PNAs. Nucleic Acids Res. 24, 494-500.
9. Karras, J. G., Maier, M. A., Lu, T., Watt, A., and Manoharan, M. (2001) Peptide nucleic acids are potent modulators of endogenous pre-mRNA splicing of the murine interleukin-5 receptor alpha chain. Biochemistry 40, 7853-7859.
10. Sazani, P., Kang, S. H., Maier, M. A., Wei, C., Dillman, J., Summerton, J., Manoharan, M., and Kole, R. (2001) Nuclear antisense effects of neutral, anionic, and cationic oligonucleotide analogs. Nucleic Acids Res. 29, 3965-3974.
11. Sazani, P., Gemignani, F., Kang, S.-H., Maier, M. A., Manoharan, M., Persmark, M., Bortner, D., and Kole, R. (2002) Systemically delivered antisense oligomers upregulate gene expression in mouse tissues. Nat. Biotechnol. 20, 1228-1233.
12. Pooga, M., Soomets, U., Hallbrink, M., Valkna, A., Saar, K., Rezaei, K., Kahl, U., Hao, J. X., Xu, X. J., Wiesenfeld-Hallin, Z., Hokfelt, T., Bartfai, T., and Langel, U. (1998) Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo. Nat. Biotechnol. 16, 857-861.
13. Mier, W., Eritja, R., Mohammed, A., Haberkorn, U., and Eisenhut, M. (2003) Peptide-PNA conjugates: Target transport of antisense therapeutics into tumors. Angew Chem. Int. Ed. 42, 1968-1971.
14. Doyle, D. F., Braasch, D. A., Simmons, C. G., Janowski, B. A., and Corey, D. R. (2001) Intracellular delivery and inhibition of gene expression by peptide nucleic acids. Biochemistry 40, 53-64.
15. Kozak, M. (2002) Emerging links between initiation of translation and human diseases. Mamm. Genome 13, 401-410,
16. Rogozin, I. B., Kochetov, A. V., Kondrashov, F. A., Koonin, E. V., and Milanesi, L. (2001) Presence of ATG triplets in 5′-untranslated regions of eukaryotic cDNAs correlates with a weak context of the start codon. Bioinformatics 17, 890-900.
17. Kozak, M. (2002) Pushing the limits of the scanning mechanism for initiation of translation. Gene 299, 1-34.
18. Smart, E. J., Graf, G. A., McNiven, M. A., Sessa, W. C., Engelman, J. A., Scherer, P. E., Okamoto, T., and Lisanti, M. P. (1999) Caveolins, liquid ordered domains, and signal transduction. Mol. Cell. Biol. 19, 7298-7304.
19. Liu, P., Rudick, M., and Anderson, R. G. W. (2002) Multiple functions of caveolin-1. J. Biol. Chem. 277, 41295-41298.
20. Scherer, P. E., Tang, Z., Chun, M., Sargiacomo, M., Lodish, H. F., and Lisanti, M. P. (1995) Caveolin isoforms differ in their N-terminal protein sequence and subcellular distribution. Identification and epitope mapping of an isoform-specific monoclonal antibody probe. J. Biol. Chem. 270, 16395-401.
21. Ramirez, M. I., Pollack, L., Millien, G., Cao, Y. X., Hinds, A., and Williams, M. C. (2002) The alpha-isoform of caveolin-1 is a marker of vascularogenesis in early lung development. J. Histochem. Cytochem. 50, 33-42.
22. Smart, E. J., Ying, Y., Donzell, W. C., and Anderson, R. G. W. (1996) A role for caveolin in transport of cholesterol from endoplasmic reticulum to plasma membrane. J. Biol. Chem. 271, 29427-29435.
23. Razani, B., Combs, T. P., Wang, X. B., Frank, P. G., Park, D. S., Russell, R. G., Li, M., Tang, B., Jelicks, L. A., Scherer, P. E., and Lisanti, M. P. (2000) Caveolin-1-deficient mice are lean, resistant to diet-induced obesity, and show hypertriglyceridemia with adipocyte abnormalities. J. Biol. Chem. 277, 8635-47.
24. Mayfield, L. D., and Corey, D. R. (1999) Automated synthesis of peptide nucleic acids (PNAs) and PNA-peptide conjugates. Anal. Biochem. 268, 401-404.
25. Hamilton, S. E., Simmons, C. G., Kathriya, I., and Corey, D. R. (1999) Cellular delivery of peptide nucleic acids and inhibition of telomerase. Chem. Biol. 6, 343-351.
26. Herbert, B.-S., Pitts, A. E., Baker, S. I., Hamilton, S. E., Wright, W. E., Shay, J. W., and Corey, D. R. (1999) Inhibition of human telomerase leads to eroded telomeres, reduced proliferation, and cell death. Proc. Natl. Acad. Sci. U.S.A. 96, 14726-14781.
27. Braasch, D. A., and Corey, D. R. (2001) Synthesis, analysis, purification, and intracellular delivery of peptide nucleic acids. Methods 23, 97-107.
28. Kogo, H., and Fujimoto, T. (2000) Caveolin-1 isoforms are encoded by distinct mRNAs. Identification of mouse caveolin-1 mRNA variants caused by alternative transcription initiation and splicing. FEBS Lett. 465, 119-123.
29. Aldred, M. A., Ginn-Pease, M. E., Morrison, C. D., Popkie, A. P., Gimm, O., Hoang-Vu, C., Krause, U., Dralle, H., Jhiang, S. M., Plass, C., and Eng, C. (2003) Caveolin-1 and caveolin-2, together with three bone morphogenetic protein-related genes, may encode novel tumor supressors down-regulated in sporadic follicular thyroid carcinogenesis. Cancer Res. 63, 2864-2871.
30. Nasevicius, A., and Ekker S. C. (2000) Effective gene targeted knock down in zebrafish. Nat. Genet. 26, 216-220.
31. Braasch, D. A., Jensen, S., Liu, Y., Arar, K., White, M. A., and Corey, D. R. (2003) RNA interference in mammalian cells by chemically modified RNA. Biochemistry 42, 7967-7975.
32. Jackson, A. L., Bartz, S. R., Schelter, J., Kobayashi, S. V., Burchard, J., Mao, M., Li, B., Cavet, G., and Linsley, P. S. (2003) Expression profiling reveals off-target gene regulation by RNAi. Nat. Biotechnol. 21, 635-7.
33. Saxena, S., Jonsson, Z. O., and Dutta, A. (2003) Small RNAs with imperfect match to endogenous mRNA repress translation: implications for off-target activity of siRNA in mammalian cells. J. Biol. Chem. 278, 44312-44319.
34. Bridge, A. J., Pebernard, S., Ducraux, A., Nicoulaz, A. L., and Iggo, R. (2003) Induction of an interferon response by RNAi vectors in mammalian cells. Nat. Genet. 34, 263-264.
35. Sledz, C. A., Holko, M., de Veer, M. J., Silverman, R. H., and Williams, B. R. (2003) Activation of the interferon system by short interfering siRNAs. Nat. Cell Biol. 5, 834-839.
36. Zender, L., Hutker, S., Liedtke, C., Tillmann, H. L., Zender, S., Mundt, B., Waltemathe, M., Gosling, T., Flemming, P., Malek, N. P., Trautwein, C., Manns, M. P., Kuhnel, F., and Kubicka, S. (2003). Caspase 8 small interfering RNA prevents acute liver failure in mice. Proc. Natl. Acad. Sci. U.S.A. 100, 7797-7802.
37. Sorensen, D. R., Leirdal, M., and Sioud, M. (2003) Gene silencing by systemic delivery of synthetic siRNAs in adult mice. J. Mol. Biol. 327, 761-766.
38. Song, E., Lee, S. K., Wang, J., Ince, N., Ouyang, N., Min, J., Chen, J., Shankar, P., and Lieberman, J. (2003) RNA interference protects targeting FAS protects mice from fulminant hepatitis. Nat. Med. 9, 347-351.
39. Braasch, D. A., Paroo, Z., Constantinescu, A., Ren, G., Oz, O., Mason, R. P., and Corey, D. R. (2004) Biodistribution of phosphodiester and phosphorothioate siRNA Bioorg. Med. Chem. Lett., in press.